Standout Papers

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial... 2005 2026 2012 2019 1.8k
  1. Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial (2005)
    Robert S. Bresalier, Robert S. Sandler et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 19 from Science/Nature 86 standout
Sub-graph 1 of 17

Citing Papers

Medical, surgical, and physical treatments for Parkinson's disease
2024 Standout
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
80 intermediate papers

Works of Christopher Lines being referenced

Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
2014
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
2008
and 13 more

Author Peers

Author Last Decade Papers Cites
Christopher Lines 1412 1228 1706 1498 76 5.7k
Tetsuo Shimizu 1368 1220 707 501 171 4.3k
Joop van Gerven 2322 1146 792 1695 168 5.8k
Laura D. Baker 714 416 1791 810 150 9.7k
Erik S. Musiek 1383 754 585 564 93 6.9k
Richard Hargreaves 855 209 1655 487 152 6.7k
Smriti Iyengar 953 183 1587 1762 62 4.9k
Paola Sarchielli 399 175 3666 540 176 6.9k
G Chazot 642 556 1242 126 117 3.9k
Alexandre de Mendonça 822 340 1462 481 121 5.3k
Régis Bordet 847 182 974 546 307 8.9k

All Works

Loading papers...

Rankless by CCL
2026